Analysis of the RIMDAMAL trial

Lancet. 2019 Sep 21;394(10203):1005-1006. doi: 10.1016/S0140-6736(19)31663-0. Epub 2019 Jul 16.

Authors

John Bradley¹, Lawrence H Moulton², Richard Hayes³

Affiliations

¹ MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. Electronic address: john.bradley@lshtm.ac.uk.
² Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
³ MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

PMID: 31324344
DOI: 10.1016/S0140-6736(19)31663-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Ivermectin
Malaria*
Mass Drug Administration*

Substances

Ivermectin